🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great summary of our recent work which focused on understanding the relationship between FGFR3i/TME and its implications for immunotherapy. William Y. Kim Marie-Pier St-Laurent Peter Black europeanurology.com/article/S0302-…

Congrats Kathryn Hacker Gessner for an amazing Pathology Grand Rounds! Can't wait to see what great science your lab produces 🧪🥼 Urology@UNC UNC Lineberger

.National Cancer Institute-funded researchers are working to improve our understanding of how to treat #BladderCancer. With recent advances in immunotherapy and targeted therapy, treatment has the potential to become more effective and less toxic. Learn more: go.nih.gov/JJ7mCj5 #NCRM24

***ONLY 1 WEEK LEFT*** The deadline to submit abstracts for IBCN2024 is rapidly approaching! Abstracts are due May 31st!! ibcnweb.com/abstracts/ Roland Seiler-Blarer Peter Black Tilman Todenhöfer Kent Mouw Lars Dyrskjøt @jeff_unc

Great job by Wolfgang Beckabir leading a fun and productive collaboration! Nature Communications Benjamin Vincent William Y. Kim Matt Milowsky UNC Lineberger UNC Microbiology and Immunology Department nature.com/articles/s4146…

Dr. Ray Tan (Ray Tan), Dr. Sara Wobker (@SaraEWobker), and Dr. Christopher Dittus help patients better understand #tumor grades and stages in this recent #UNCHealthTalk article: med.unc.edu/urology/unders…

We are so proud to announce the recipients of the BCAN 2024 Research Innovation Awards, Dr. Bishoy M. Faltas of Weill Cornell Medicine and Alex Wyatt of University of British Columbia. We encourage you to read more about their innovative proposals here: bcan.org/2024-bladder-c…. Congratulations Drs. Faltas and Wyatt!

Congratulations to everyone involved in the inaugural young-onset bladder cancer session at #BCANTT24! We’ll definitely be translating this momentum into a dedicated working group. Special shoutout to Shilpa Gupta for the enthusiasm and energy that made this breakout such a

🎯🎯🎯 JAMA review of Renal Cell Carcinoma from local heroes Tracy Rose & William Y. Kim #GoHeels 👀➡️ jamanetwork.com/journals/jama/…

Only 24hrs until #IBCN2024 with a record number of attendees! Looking forward to an incredible lineup of speakers and great scientific program. ibcnweb.com/program_2024/ Peter Black Lars Dyrskjøt Kent Mouw Tilman Todenhöfer Roland Seiler-Blarer Jeffrey Damrauer

Yay Emily! Keep up the great work!!

Excited to share our urine tumor DNA assay #UroScout results published today in European Urology 👉 authors.elsevier.com/c/1jzvn14kplyz… Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis 🧬 497 urine DNA samples from 281 patients ✅100% sens for ≥T1 bladder cancer ✅

Here is a direct link to the paper rdcu.be/d5puQ

Save the Date for IBCN's Annual Meeting!! Oct. 9-11, 2025 Munich, Germany

IBCN 2025 - Munich (Oct. 9-11): Registration and abstract submission opens Monday May 12!!

We are proud to launch the IBCN Exchange Grant, supporting early-career researchers in bladder cancer through international, short-term, research exchanges within the IBCN community. For more info and details or to become an IBCN member please visit: ibcnweb.com

***Only 1 week remaining*** Deadline is June 30th to submit abstracts and travel award applications for IBCN 2025 - Munich, Germany! ibcnweb.com/ibcn-abstract-… ibcnweb.com/travel_award/ Peter Black Lars Dyrskjøt Tilman Todenhöfer Roland Seiler-Blarer Kent Mouw Madhuri Koti Jeffrey Damrauer

ONE MORE DAY! Tomorrow is the deadline to submit abstracts and travel award applications for IBCN 2025 - Munich, Germany! ibcnweb.com/ibcn-abstract-… ibcnweb.com/travel_award/ Peter Black Lars Dyrskjøt Tilman Todenhöfer Roland Seiler-Blarer Kent Mouw Madhuri Koti Jeffrey Damrauer